Literature DB >> 31626796

Tissue dissemination and humoral response after experimental reinfection with atypical Toxoplasma gondii strains obtained from congenital human toxoplasmosis in Brazil.

Gabriella Lima Bessa1, Júlia Gatti Ladeia Costa1, Wagner Martins Fontes Rêgo1, Ramon Castro Araújo Baraviera1, Lorena Velozo Pinto1, Rosálida Estevam Nazar Lopes1, Ricardo Wagner Almeida Vitor2.   

Abstract

The paradigm that Toxoplasma gondii infection generates sterilizing protective immunity was broken by case studies in which reinfections were observed in immunocompetent pregnant women in the chronic phase of toxoplasmosis. Since then, several murine models have suggested that immunoprotection against a previous T. gondii infection may be violated after reinfection with strains of different genotypes. This study aimed to evaluate the dissemination of the parasite after reinfection with the virulent TgCTBr9 and EGS strains in BALB/c mice chronically infected with the avirulent TgCTBr5 strain. Three mice were euthanized at 2, 4, 8, 12, 24 and 48 h post challenge (p.c.) and at 7, 14 and 30 days p.c. Intestines, mesenteric lymph nodes, lungs and brains were collected for PCR-RFLP. Blood samples were collected to measure total IgG, IgG1 and IgG2a by ELISA. The reinfected animals survived and presented reduced morbidity after challenge with the virulent strains. Mice challenged with the TgCTBr9 strain showed a slight increase in anti-T. gondii IgG1. The spread of the TgCTBr5 strain was observed to occur earlier than the dissemination of the virulent TgCTBr9 or EGS strains. The TgCTBr9 strain was observed in the mesenteric lymph node at 7 days post challenge (d.p.c.); in the intestine and lungs at 14 d.p.c.; and in the brain at 30 d.p.c. EGS strain was demonstrated in the mesenteric lymph node and lung at 7 d.p.c and in the intestine and brain at a later time point. The immune response promoted by the primary infection with the avirulent strain (TgCTBr5) protected the animals from death after challenge with the virulent strains (TgCTBr9 or EGS).
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Genotyping; Humoral immunity; PCR-RFLP; Reinfection; Toxoplasma gondii

Mesh:

Substances:

Year:  2019        PMID: 31626796     DOI: 10.1016/j.exppara.2019.107781

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  2 in total

Review 1.  Toxoplasma gondii in South America: a differentiated pattern of spread, population structure and clinical manifestations.

Authors:  Gabriella de Lima Bessa; Ricardo Wagner de Almeida Vitor; Erica Dos Santos Martins-Duarte
Journal:  Parasitol Res       Date:  2021-08-14       Impact factor: 2.289

Review 2.  Anti-Toxoplasma gondii IgM Long Persistence: What Are the Underlying Mechanisms?

Authors:  José Antonio Vargas-Villavicencio; Irma Cañedo-Solares; Dolores Correa
Journal:  Microorganisms       Date:  2022-08-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.